
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6483523
[patent_doc_number] => 20100008954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Alpha-galactosyl ceramide analogs and their use as immunotherapies'
[patent_app_type] => utility
[patent_app_number] => 12/218082
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 114
[patent_figures_cnt] => 114
[patent_no_of_words] => 25688
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008954.pdf
[firstpage_image] =>[orig_patent_app_number] => 12218082
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/218082 | Alpha-galactosyl ceramide analogs and their use as immunotherapies | Jul 10, 2008 | Issued |
Array
(
[id] => 4886380
[patent_doc_number] => 20080260712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability'
[patent_app_type] => utility
[patent_app_number] => 12/214597
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10162
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260712.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214597
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214597 | Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability | Jun 19, 2008 | Abandoned |
Array
(
[id] => 4600169
[patent_doc_number] => 07977473
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-07-12
[patent_title] => 'Use of non-crystalline cellulose as a medicine tablet medium'
[patent_app_type] => utility
[patent_app_number] => 12/214661
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 9235
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214661 | Use of non-crystalline cellulose as a medicine tablet medium | Jun 19, 2008 | Issued |
Array
(
[id] => 6446483
[patent_doc_number] => 20100279961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/665879
[patent_app_country] => US
[patent_app_date] => 2008-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2426
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279961.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665879
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665879 | PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE | Jun 16, 2008 | Abandoned |
Array
(
[id] => 8152568
[patent_doc_number] => 08168803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Methods of using [3.2.0] heterocyclic compounds and analogs thereof'
[patent_app_type] => utility
[patent_app_number] => 12/136688
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 52
[patent_no_of_words] => 36164
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12136688
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136688 | Methods of using [3.2.0] heterocyclic compounds and analogs thereof | Jun 9, 2008 | Issued |
Array
(
[id] => 4823086
[patent_doc_number] => 20080227729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/130907
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9371
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130907
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130907 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | May 29, 2008 | Issued |
Array
(
[id] => 4494577
[patent_doc_number] => 07956181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Trehalose fatty acid ester composition'
[patent_app_type] => utility
[patent_app_number] => 12/128023
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26472
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956181.pdf
[firstpage_image] =>[orig_patent_app_number] => 12128023
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128023 | Trehalose fatty acid ester composition | May 27, 2008 | Issued |
Array
(
[id] => 8245054
[patent_doc_number] => 08202983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Thiocarbon-protecting groups for RNA synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/118655
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26913
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12118655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/118655 | Thiocarbon-protecting groups for RNA synthesis | May 8, 2008 | Issued |
Array
(
[id] => 4470000
[patent_doc_number] => 07943596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Medicinal composition for ophthal use containing acetylated hyaluronic acid'
[patent_app_type] => utility
[patent_app_number] => 12/151702
[patent_app_country] => US
[patent_app_date] => 2008-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3348
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12151702
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/151702 | Medicinal composition for ophthal use containing acetylated hyaluronic acid | May 7, 2008 | Issued |
Array
(
[id] => 4960575
[patent_doc_number] => 20080275000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/114872
[patent_app_country] => US
[patent_app_date] => 2008-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7391
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275000.pdf
[firstpage_image] =>[orig_patent_app_number] => 12114872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/114872 | COMPOSITIONS FOR REDUCING, AMELIORATING, TREATING, OR PREVENTING CONDITION OF DRY EYE AND METHODS OF MAKING AND USING SAME | May 4, 2008 | Abandoned |
Array
(
[id] => 4860396
[patent_doc_number] => 20080269246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'METHOD FOR TREATING PEDIATRIC BIPOLAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 12/110522
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8919
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269246.pdf
[firstpage_image] =>[orig_patent_app_number] => 12110522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/110522 | METHOD FOR TREATING PEDIATRIC BIPOLAR DISORDER | Apr 27, 2008 | Abandoned |
Array
(
[id] => 7535377
[patent_doc_number] => 08049003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/108228
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18396
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/049/08049003.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108228 | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof | Apr 22, 2008 | Issued |
Array
(
[id] => 4676863
[patent_doc_number] => 20080214494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'METHOD OF DRUG DELIVERY BY CARBON NANOTUBE-CHITOSAN NANOCOMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 12/105884
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5454
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214494.pdf
[firstpage_image] =>[orig_patent_app_number] => 12105884
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/105884 | Method of drug delivery by carbon nanotube-chitosan nanocomplexes | Apr 17, 2008 | Issued |
Array
(
[id] => 4886442
[patent_doc_number] => 20080260774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Alpha-galactosyl ceramide analogs and their use as immunotherapies'
[patent_app_type] => utility
[patent_app_number] => 12/082751
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 70
[patent_no_of_words] => 26099
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260774.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082751 | Alpha-galactosyl ceramide analogs and their use as immunotherapies | Apr 13, 2008 | Abandoned |
Array
(
[id] => 4813866
[patent_doc_number] => 20080194497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'MACROLIDE POLYMORPHS, COMPOSITIONS COMPRISING SUCH POLYMORPHS, AND METHODS OF USE AND MANUFACTURE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/101552
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12893
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101552
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101552 | Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Apr 10, 2008 | Issued |
Array
(
[id] => 9184073
[patent_doc_number] => 08624006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'One-pot synthesis of alpha/beta-O-glycolipids'
[patent_app_type] => utility
[patent_app_number] => 12/595214
[patent_app_country] => US
[patent_app_date] => 2008-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13306
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595214 | One-pot synthesis of alpha/beta-O-glycolipids | Apr 7, 2008 | Issued |
Array
(
[id] => 9286242
[patent_doc_number] => 08642572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Cytidine derivative-containing antitumor agent for continuous intravenous administration'
[patent_app_type] => utility
[patent_app_number] => 12/594823
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3700
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594823 | Cytidine derivative-containing antitumor agent for continuous intravenous administration | Apr 3, 2008 | Issued |
Array
(
[id] => 6412147
[patent_doc_number] => 20100166727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'S-Adenosylmethionine And Methylthioadensosine In Chemoprevention And Treatment Of Colon Polyps And Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/594567
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 19196
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594567
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594567 | S-Adenosylmethionine And Methylthioadensosine In Chemoprevention And Treatment Of Colon Polyps And Cancer | Apr 1, 2008 | Abandoned |
Array
(
[id] => 5297113
[patent_doc_number] => 20090012039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Use of methylcobalamin nasal spray to treat disorders'
[patent_app_type] => utility
[patent_app_number] => 12/077296
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3961
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077296 | Use of methylcobalamin nasal spray to treat disorders | Mar 16, 2008 | Abandoned |
Array
(
[id] => 6454231
[patent_doc_number] => 20100105634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'USE OF GLUCOSAMINE AS A MENTAL AND PHYSICAL STRESS RECOVERY ENHANCER AND A PERFORMANCE ENHANCER'
[patent_app_type] => utility
[patent_app_number] => 12/529978
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6716
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105634.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529978
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529978 | USE OF GLUCOSAMINE AS A MENTAL AND PHYSICAL STRESS RECOVERY ENHANCER AND A PERFORMANCE ENHANCER | Mar 6, 2008 | Abandoned |